CD274 and cervical carcinoma: Recently, using neoadjuvant chemotherapy (NAC) to treat patients with cervical cancer, researchers found that the proportion of patients with high expression of PD‐L1 increased significantly from 32.4% to 46.5%, indicating that chemotherapy can PD‐L1 expression in cervical cancer.100